Biomarkers for transitional cell carcinoma - CON

Urology

Volumn 57, Issue 5, 2001, Pages 849-851

  Schoenberg, Mark ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYCLINE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER; UVOMORULIN;

BLADDER CANCER; CANCER STAGING; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, SMALL CELL; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0035038141     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)00975-X     Document Type: Editorial

References (9)

1. Total cystectomy for bladder tumors
2. Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer; a utility analysis
3. Molecular diagnosis and staging of bladder cancer
4. The use of molecular diagnostics in bladder cancer
5. 5 year follow-up of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guérin in patients with superficial bladder carcinoma
6. Biological markers in superficial bladder tumors and their prognostic significance
7. Association of p53 nuclear over expression and tumor progression in carcinoma in situ of the bladder
8. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer; 10-year followup